Global HMO Infant Formula Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global HMO Infant Formula market size was valued at US$ 4358 million in 2025 and is forecast to a readjusted size of US$ 8743 million by 2032 with a CAGR of 10.6% during review period.
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Global key players of HMO Infant Formula include Nestl? (Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Abbott, Mead Johnson(Reckitt), etc. The top five players hold a share about 94%. Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately. In terms of product type, 2'-FL is the largest segment, accounting for a share about 96%. In terms of application, Online Channel is the largest field with a share about 33 percent.
This report is a detailed and comprehensive analysis for global HMO Infant Formula market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HMO Infant Formula market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global HMO Infant Formula market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global HMO Infant Formula market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global HMO Infant Formula market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HMO Infant Formula
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HMO Infant Formula market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Mead Johnson?Reckitt?, Nestl??Wyeth Nutrition?, Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HMO Infant Formula market is split by Type and by Sales Channel. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HMO Infant Formula product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HMO Infant Formula, with price, sales quantity, revenue, and global market share of HMO Infant Formula from 2021 to 2026.
Chapter 3, the HMO Infant Formula competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HMO Infant Formula breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Sales Channel, with sales market share and growth rate by Type, by Sales Channel, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and HMO Infant Formula market forecast, by regions, by Type, and by Sales Channel, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HMO Infant Formula.
Chapter 14 and 15, to describe HMO Infant Formula sales channel, distributors, customers, research findings and conclusion.
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Global key players of HMO Infant Formula include Nestl? (Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Abbott, Mead Johnson(Reckitt), etc. The top five players hold a share about 94%. Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately. In terms of product type, 2'-FL is the largest segment, accounting for a share about 96%. In terms of application, Online Channel is the largest field with a share about 33 percent.
This report is a detailed and comprehensive analysis for global HMO Infant Formula market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HMO Infant Formula market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global HMO Infant Formula market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global HMO Infant Formula market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global HMO Infant Formula market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HMO Infant Formula
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HMO Infant Formula market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Mead Johnson?Reckitt?, Nestl??Wyeth Nutrition?, Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HMO Infant Formula market is split by Type and by Sales Channel. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 2'-Fucosyllactose (2'-FL)
- Others
- Online Channel
- Specialty Store
- Supermarket
- Others
- Abbott
- Mead Johnson?Reckitt?
- Nestl??Wyeth Nutrition?
- Danone (Aptamil)
- FrieslandCampina (Friso)
- Biostime
- Yili Group (Ausnutria Dairy)
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HMO Infant Formula product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HMO Infant Formula, with price, sales quantity, revenue, and global market share of HMO Infant Formula from 2021 to 2026.
Chapter 3, the HMO Infant Formula competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HMO Infant Formula breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Sales Channel, with sales market share and growth rate by Type, by Sales Channel, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and HMO Infant Formula market forecast, by regions, by Type, and by Sales Channel, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HMO Infant Formula.
Chapter 14 and 15, to describe HMO Infant Formula sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HMO Infant Formula Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 2'-Fucosyllactose (2'-FL)
1.3.3 Others
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global HMO Infant Formula Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
1.4.2 Online Channel
1.4.3 Specialty Store
1.4.4 Supermarket
1.4.5 Others
1.5 Global HMO Infant Formula Market Size & Forecast
1.5.1 Global HMO Infant Formula Consumption Value (2021 & 2025 & 2032)
1.5.2 Global HMO Infant Formula Sales Quantity (2021-2032)
1.5.3 Global HMO Infant Formula Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott HMO Infant Formula Product and Services
2.1.4 Abbott HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Abbott Recent Developments/Updates
2.2 Mead Johnson?Reckitt?
2.2.1 Mead Johnson?Reckitt? Details
2.2.2 Mead Johnson?Reckitt? Major Business
2.2.3 Mead Johnson?Reckitt? HMO Infant Formula Product and Services
2.2.4 Mead Johnson?Reckitt? HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Mead Johnson?Reckitt? Recent Developments/Updates
2.3 Nestl??Wyeth Nutrition?
2.3.1 Nestl??Wyeth Nutrition? Details
2.3.2 Nestl??Wyeth Nutrition? Major Business
2.3.3 Nestl??Wyeth Nutrition? HMO Infant Formula Product and Services
2.3.4 Nestl??Wyeth Nutrition? HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Nestl??Wyeth Nutrition? Recent Developments/Updates
2.4 Danone (Aptamil)
2.4.1 Danone (Aptamil) Details
2.4.2 Danone (Aptamil) Major Business
2.4.3 Danone (Aptamil) HMO Infant Formula Product and Services
2.4.4 Danone (Aptamil) HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Danone (Aptamil) Recent Developments/Updates
2.5 FrieslandCampina (Friso)
2.5.1 FrieslandCampina (Friso) Details
2.5.2 FrieslandCampina (Friso) Major Business
2.5.3 FrieslandCampina (Friso) HMO Infant Formula Product and Services
2.5.4 FrieslandCampina (Friso) HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 FrieslandCampina (Friso) Recent Developments/Updates
2.6 Biostime
2.6.1 Biostime Details
2.6.2 Biostime Major Business
2.6.3 Biostime HMO Infant Formula Product and Services
2.6.4 Biostime HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Biostime Recent Developments/Updates
2.7 Yili Group (Ausnutria Dairy)
2.7.1 Yili Group (Ausnutria Dairy) Details
2.7.2 Yili Group (Ausnutria Dairy) Major Business
2.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Product and Services
2.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Yili Group (Ausnutria Dairy) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HMO INFANT FORMULA BY MANUFACTURER
3.1 Global HMO Infant Formula Sales Quantity by Manufacturer (2021-2026)
3.2 Global HMO Infant Formula Revenue by Manufacturer (2021-2026)
3.3 Global HMO Infant Formula Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of HMO Infant Formula by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 HMO Infant Formula Manufacturer Market Share in 2025
3.4.3 Top 6 HMO Infant Formula Manufacturer Market Share in 2025
3.5 HMO Infant Formula Market: Overall Company Footprint Analysis
3.5.1 HMO Infant Formula Market: Region Footprint
3.5.2 HMO Infant Formula Market: Company Product Type Footprint
3.5.3 HMO Infant Formula Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HMO Infant Formula Market Size by Region
4.1.1 Global HMO Infant Formula Sales Quantity by Region (2021-2032)
4.1.2 Global HMO Infant Formula Consumption Value by Region (2021-2032)
4.1.3 Global HMO Infant Formula Average Price by Region (2021-2032)
4.2 North America HMO Infant Formula Consumption Value (2021-2032)
4.3 Europe HMO Infant Formula Consumption Value (2021-2032)
4.4 Asia-Pacific HMO Infant Formula Consumption Value (2021-2032)
4.5 South America HMO Infant Formula Consumption Value (2021-2032)
4.6 Middle East & Africa HMO Infant Formula Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global HMO Infant Formula Sales Quantity by Type (2021-2032)
5.2 Global HMO Infant Formula Consumption Value by Type (2021-2032)
5.3 Global HMO Infant Formula Average Price by Type (2021-2032)
6 MARKET SEGMENT BY SALES CHANNEL
6.1 Global HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
6.2 Global HMO Infant Formula Consumption Value by Sales Channel (2021-2032)
6.3 Global HMO Infant Formula Average Price by Sales Channel (2021-2032)
7 NORTH AMERICA
7.1 North America HMO Infant Formula Sales Quantity by Type (2021-2032)
7.2 North America HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
7.3 North America HMO Infant Formula Market Size by Country
7.3.1 North America HMO Infant Formula Sales Quantity by Country (2021-2032)
7.3.2 North America HMO Infant Formula Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe HMO Infant Formula Sales Quantity by Type (2021-2032)
8.2 Europe HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
8.3 Europe HMO Infant Formula Market Size by Country
8.3.1 Europe HMO Infant Formula Sales Quantity by Country (2021-2032)
8.3.2 Europe HMO Infant Formula Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific HMO Infant Formula Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
9.3 Asia-Pacific HMO Infant Formula Market Size by Region
9.3.1 Asia-Pacific HMO Infant Formula Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific HMO Infant Formula Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America HMO Infant Formula Sales Quantity by Type (2021-2032)
10.2 South America HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
10.3 South America HMO Infant Formula Market Size by Country
10.3.1 South America HMO Infant Formula Sales Quantity by Country (2021-2032)
10.3.2 South America HMO Infant Formula Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HMO Infant Formula Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
11.3 Middle East & Africa HMO Infant Formula Market Size by Country
11.3.1 Middle East & Africa HMO Infant Formula Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa HMO Infant Formula Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 HMO Infant Formula Market Drivers
12.2 HMO Infant Formula Market Restraints
12.3 HMO Infant Formula Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HMO Infant Formula and Key Manufacturers
13.2 Manufacturing Costs Percentage of HMO Infant Formula
13.3 HMO Infant Formula Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HMO Infant Formula Typical Distributors
14.3 HMO Infant Formula Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HMO Infant Formula Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 2'-Fucosyllactose (2'-FL)
1.3.3 Others
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global HMO Infant Formula Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
1.4.2 Online Channel
1.4.3 Specialty Store
1.4.4 Supermarket
1.4.5 Others
1.5 Global HMO Infant Formula Market Size & Forecast
1.5.1 Global HMO Infant Formula Consumption Value (2021 & 2025 & 2032)
1.5.2 Global HMO Infant Formula Sales Quantity (2021-2032)
1.5.3 Global HMO Infant Formula Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott HMO Infant Formula Product and Services
2.1.4 Abbott HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Abbott Recent Developments/Updates
2.2 Mead Johnson?Reckitt?
2.2.1 Mead Johnson?Reckitt? Details
2.2.2 Mead Johnson?Reckitt? Major Business
2.2.3 Mead Johnson?Reckitt? HMO Infant Formula Product and Services
2.2.4 Mead Johnson?Reckitt? HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Mead Johnson?Reckitt? Recent Developments/Updates
2.3 Nestl??Wyeth Nutrition?
2.3.1 Nestl??Wyeth Nutrition? Details
2.3.2 Nestl??Wyeth Nutrition? Major Business
2.3.3 Nestl??Wyeth Nutrition? HMO Infant Formula Product and Services
2.3.4 Nestl??Wyeth Nutrition? HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Nestl??Wyeth Nutrition? Recent Developments/Updates
2.4 Danone (Aptamil)
2.4.1 Danone (Aptamil) Details
2.4.2 Danone (Aptamil) Major Business
2.4.3 Danone (Aptamil) HMO Infant Formula Product and Services
2.4.4 Danone (Aptamil) HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Danone (Aptamil) Recent Developments/Updates
2.5 FrieslandCampina (Friso)
2.5.1 FrieslandCampina (Friso) Details
2.5.2 FrieslandCampina (Friso) Major Business
2.5.3 FrieslandCampina (Friso) HMO Infant Formula Product and Services
2.5.4 FrieslandCampina (Friso) HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 FrieslandCampina (Friso) Recent Developments/Updates
2.6 Biostime
2.6.1 Biostime Details
2.6.2 Biostime Major Business
2.6.3 Biostime HMO Infant Formula Product and Services
2.6.4 Biostime HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Biostime Recent Developments/Updates
2.7 Yili Group (Ausnutria Dairy)
2.7.1 Yili Group (Ausnutria Dairy) Details
2.7.2 Yili Group (Ausnutria Dairy) Major Business
2.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Product and Services
2.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Yili Group (Ausnutria Dairy) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HMO INFANT FORMULA BY MANUFACTURER
3.1 Global HMO Infant Formula Sales Quantity by Manufacturer (2021-2026)
3.2 Global HMO Infant Formula Revenue by Manufacturer (2021-2026)
3.3 Global HMO Infant Formula Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of HMO Infant Formula by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 HMO Infant Formula Manufacturer Market Share in 2025
3.4.3 Top 6 HMO Infant Formula Manufacturer Market Share in 2025
3.5 HMO Infant Formula Market: Overall Company Footprint Analysis
3.5.1 HMO Infant Formula Market: Region Footprint
3.5.2 HMO Infant Formula Market: Company Product Type Footprint
3.5.3 HMO Infant Formula Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HMO Infant Formula Market Size by Region
4.1.1 Global HMO Infant Formula Sales Quantity by Region (2021-2032)
4.1.2 Global HMO Infant Formula Consumption Value by Region (2021-2032)
4.1.3 Global HMO Infant Formula Average Price by Region (2021-2032)
4.2 North America HMO Infant Formula Consumption Value (2021-2032)
4.3 Europe HMO Infant Formula Consumption Value (2021-2032)
4.4 Asia-Pacific HMO Infant Formula Consumption Value (2021-2032)
4.5 South America HMO Infant Formula Consumption Value (2021-2032)
4.6 Middle East & Africa HMO Infant Formula Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global HMO Infant Formula Sales Quantity by Type (2021-2032)
5.2 Global HMO Infant Formula Consumption Value by Type (2021-2032)
5.3 Global HMO Infant Formula Average Price by Type (2021-2032)
6 MARKET SEGMENT BY SALES CHANNEL
6.1 Global HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
6.2 Global HMO Infant Formula Consumption Value by Sales Channel (2021-2032)
6.3 Global HMO Infant Formula Average Price by Sales Channel (2021-2032)
7 NORTH AMERICA
7.1 North America HMO Infant Formula Sales Quantity by Type (2021-2032)
7.2 North America HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
7.3 North America HMO Infant Formula Market Size by Country
7.3.1 North America HMO Infant Formula Sales Quantity by Country (2021-2032)
7.3.2 North America HMO Infant Formula Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe HMO Infant Formula Sales Quantity by Type (2021-2032)
8.2 Europe HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
8.3 Europe HMO Infant Formula Market Size by Country
8.3.1 Europe HMO Infant Formula Sales Quantity by Country (2021-2032)
8.3.2 Europe HMO Infant Formula Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific HMO Infant Formula Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
9.3 Asia-Pacific HMO Infant Formula Market Size by Region
9.3.1 Asia-Pacific HMO Infant Formula Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific HMO Infant Formula Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America HMO Infant Formula Sales Quantity by Type (2021-2032)
10.2 South America HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
10.3 South America HMO Infant Formula Market Size by Country
10.3.1 South America HMO Infant Formula Sales Quantity by Country (2021-2032)
10.3.2 South America HMO Infant Formula Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HMO Infant Formula Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa HMO Infant Formula Sales Quantity by Sales Channel (2021-2032)
11.3 Middle East & Africa HMO Infant Formula Market Size by Country
11.3.1 Middle East & Africa HMO Infant Formula Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa HMO Infant Formula Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 HMO Infant Formula Market Drivers
12.2 HMO Infant Formula Market Restraints
12.3 HMO Infant Formula Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HMO Infant Formula and Key Manufacturers
13.2 Manufacturing Costs Percentage of HMO Infant Formula
13.3 HMO Infant Formula Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HMO Infant Formula Typical Distributors
14.3 HMO Infant Formula Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF FIGURES
Table 1. Global HMO Infant Formula Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global HMO Infant Formula Consumption Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott HMO Infant Formula Product and Services
Table 6. Abbott HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Abbott Recent Developments/Updates
Table 8. Mead Johnson?Reckitt? Basic Information, Manufacturing Base and Competitors
Table 9. Mead Johnson?Reckitt? Major Business
Table 10. Mead Johnson?Reckitt? HMO Infant Formula Product and Services
Table 11. Mead Johnson?Reckitt? HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Mead Johnson?Reckitt? Recent Developments/Updates
Table 13. Nestl??Wyeth Nutrition? Basic Information, Manufacturing Base and Competitors
Table 14. Nestl??Wyeth Nutrition? Major Business
Table 15. Nestl??Wyeth Nutrition? HMO Infant Formula Product and Services
Table 16. Nestl??Wyeth Nutrition? HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Nestl??Wyeth Nutrition? Recent Developments/Updates
Table 18. Danone (Aptamil) Basic Information, Manufacturing Base and Competitors
Table 19. Danone (Aptamil) Major Business
Table 20. Danone (Aptamil) HMO Infant Formula Product and Services
Table 21. Danone (Aptamil) HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Danone (Aptamil) Recent Developments/Updates
Table 23. FrieslandCampina (Friso) Basic Information, Manufacturing Base and Competitors
Table 24. FrieslandCampina (Friso) Major Business
Table 25. FrieslandCampina (Friso) HMO Infant Formula Product and Services
Table 26. FrieslandCampina (Friso) HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. FrieslandCampina (Friso) Recent Developments/Updates
Table 28. Biostime Basic Information, Manufacturing Base and Competitors
Table 29. Biostime Major Business
Table 30. Biostime HMO Infant Formula Product and Services
Table 31. Biostime HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Biostime Recent Developments/Updates
Table 33. Yili Group (Ausnutria Dairy) Basic Information, Manufacturing Base and Competitors
Table 34. Yili Group (Ausnutria Dairy) Major Business
Table 35. Yili Group (Ausnutria Dairy) HMO Infant Formula Product and Services
Table 36. Yili Group (Ausnutria Dairy) HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Yili Group (Ausnutria Dairy) Recent Developments/Updates
Table 38. Global HMO Infant Formula Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 39. Global HMO Infant Formula Revenue by Manufacturer (2021-2026) & (USD Million)
Table 40. Global HMO Infant Formula Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 41. Market Position of Manufacturers in HMO Infant Formula, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 42. Head Office and HMO Infant Formula Production Site of Key Manufacturer
Table 43. HMO Infant Formula Market: Company Product Type Footprint
Table 44. HMO Infant Formula Market: Company Product Application Footprint
Table 45. HMO Infant Formula New Market Entrants and Barriers to Market Entry
Table 46. HMO Infant Formula Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global HMO Infant Formula Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 48. Global HMO Infant Formula Sales Quantity by Region (2021-2026) & (Tons)
Table 49. Global HMO Infant Formula Sales Quantity by Region (2027-2032) & (Tons)
Table 50. Global HMO Infant Formula Consumption Value by Region (2021-2026) & (USD Million)
Table 51. Global HMO Infant Formula Consumption Value by Region (2027-2032) & (USD Million)
Table 52. Global HMO Infant Formula Average Price by Region (2021-2026) & (US$/kg)
Table 53. Global HMO Infant Formula Average Price by Region (2027-2032) & (US$/kg)
Table 54. Global HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 55. Global HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 56. Global HMO Infant Formula Consumption Value by Type (2021-2026) & (USD Million)
Table 57. Global HMO Infant Formula Consumption Value by Type (2027-2032) & (USD Million)
Table 58. Global HMO Infant Formula Average Price by Type (2021-2026) & (US$/kg)
Table 59. Global HMO Infant Formula Average Price by Type (2027-2032) & (US$/kg)
Table 60. Global HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 61. Global HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 62. Global HMO Infant Formula Consumption Value by Sales Channel (2021-2026) & (USD Million)
Table 63. Global HMO Infant Formula Consumption Value by Sales Channel (2027-2032) & (USD Million)
Table 64. Global HMO Infant Formula Average Price by Sales Channel (2021-2026) & (US$/kg)
Table 65. Global HMO Infant Formula Average Price by Sales Channel (2027-2032) & (US$/kg)
Table 66. North America HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 67. North America HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 68. North America HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 69. North America HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 70. North America HMO Infant Formula Sales Quantity by Country (2021-2026) & (Tons)
Table 71. North America HMO Infant Formula Sales Quantity by Country (2027-2032) & (Tons)
Table 72. North America HMO Infant Formula Consumption Value by Country (2021-2026) & (USD Million)
Table 73. North America HMO Infant Formula Consumption Value by Country (2027-2032) & (USD Million)
Table 74. Europe HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 75. Europe HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 76. Europe HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 77. Europe HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 78. Europe HMO Infant Formula Sales Quantity by Country (2021-2026) & (Tons)
Table 79. Europe HMO Infant Formula Sales Quantity by Country (2027-2032) & (Tons)
Table 80. Europe HMO Infant Formula Consumption Value by Country (2021-2026) & (USD Million)
Table 81. Europe HMO Infant Formula Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Asia-Pacific HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 83. Asia-Pacific HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 84. Asia-Pacific HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 85. Asia-Pacific HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 86. Asia-Pacific HMO Infant Formula Sales Quantity by Region (2021-2026) & (Tons)
Table 87. Asia-Pacific HMO Infant Formula Sales Quantity by Region (2027-2032) & (Tons)
Table 88. Asia-Pacific HMO Infant Formula Consumption Value by Region (2021-2026) & (USD Million)
Table 89. Asia-Pacific HMO Infant Formula Consumption Value by Region (2027-2032) & (USD Million)
Table 90. South America HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 91. South America HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 92. South America HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 93. South America HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 94. South America HMO Infant Formula Sales Quantity by Country (2021-2026) & (Tons)
Table 95. South America HMO Infant Formula Sales Quantity by Country (2027-2032) & (Tons)
Table 96. South America HMO Infant Formula Consumption Value by Country (2021-2026) & (USD Million)
Table 97. South America HMO Infant Formula Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Middle East & Africa HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 99. Middle East & Africa HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 100. Middle East & Africa HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 101. Middle East & Africa HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 102. Middle East & Africa HMO Infant Formula Sales Quantity by Country (2021-2026) & (Tons)
Table 103. Middle East & Africa HMO Infant Formula Sales Quantity by Country (2027-2032) & (Tons)
Table 104. Middle East & Africa HMO Infant Formula Consumption Value by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa HMO Infant Formula Consumption Value by Country (2027-2032) & (USD Million)
Table 106. HMO Infant Formula Raw Material
Table 107. Key Manufacturers of HMO Infant Formula Raw Materials
Table 108. HMO Infant Formula Typical Distributors
Table 109. HMO Infant Formula Typical Customers
LIST OF FIGURES
Figure 1. HMO Infant Formula Picture
Figure 2. Global HMO Infant Formula Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global HMO Infant Formula Revenue Market Share by Type in 2025
Figure 4. 2'-Fucosyllactose (2'-FL) Examples
Figure 5. Others Examples
Figure 6. Global HMO Infant Formula Consumption Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 7. Global HMO Infant Formula Revenue Market Share by Sales Channel in 2025
Figure 8. Online Channel Examples
Figure 9. Specialty Store Examples
Figure 10. Supermarket Examples
Figure 11. Others Examples
Figure 12. Global HMO Infant Formula Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global HMO Infant Formula Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global HMO Infant Formula Sales Quantity (2021-2032) & (Tons)
Figure 15. Global HMO Infant Formula Price (2021-2032) & (US$/kg)
Figure 16. Global HMO Infant Formula Sales Quantity Market Share by Manufacturer in 2025
Figure 17. Global HMO Infant Formula Revenue Market Share by Manufacturer in 2025
Figure 18. Producer Shipments of HMO Infant Formula by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 19. Top 3 HMO Infant Formula Manufacturer (Revenue) Market Share in 2025
Figure 20. Top 6 HMO Infant Formula Manufacturer (Revenue) Market Share in 2025
Figure 21. Global HMO Infant Formula Sales Quantity Market Share by Region (2021-2032)
Figure 22. Global HMO Infant Formula Consumption Value Market Share by Region (2021-2032)
Figure 23. North America HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 26. South America HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 28. Global HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 29. Global HMO Infant Formula Consumption Value Market Share by Type (2021-2032)
Figure 30. Global HMO Infant Formula Average Price by Type (2021-2032) & (US$/kg)
Figure 31. Global HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 32. Global HMO Infant Formula Revenue Market Share by Sales Channel (2021-2032)
Figure 33. Global HMO Infant Formula Average Price by Sales Channel (2021-2032) & (US$/kg)
Figure 34. North America HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 35. North America HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 36. North America HMO Infant Formula Sales Quantity Market Share by Country (2021-2032)
Figure 37. North America HMO Infant Formula Consumption Value Market Share by Country (2021-2032)
Figure 38. United States HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 42. Europe HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 43. Europe HMO Infant Formula Sales Quantity Market Share by Country (2021-2032)
Figure 44. Europe HMO Infant Formula Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 46. France HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 51. Asia-Pacific HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 52. Asia-Pacific HMO Infant Formula Sales Quantity Market Share by Region (2021-2032)
Figure 53. Asia-Pacific HMO Infant Formula Consumption Value Market Share by Region (2021-2032)
Figure 54. China HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 57. India HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 60. South America HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 61. South America HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 62. South America HMO Infant Formula Sales Quantity Market Share by Country (2021-2032)
Figure 63. South America HMO Infant Formula Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 67. Middle East & Africa HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 68. Middle East & Africa HMO Infant Formula Sales Quantity Market Share by Country (2021-2032)
Figure 69. Middle East & Africa HMO Infant Formula Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 71. Egypt HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 73. South Africa HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 74. HMO Infant Formula Market Drivers
Figure 75. HMO Infant Formula Market Restraints
Figure 76. HMO Infant Formula Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of HMO Infant Formula in 2025
Figure 79. Manufacturing Process Analysis of HMO Infant Formula
Figure 80. HMO Infant Formula Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Table 1. Global HMO Infant Formula Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global HMO Infant Formula Consumption Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott HMO Infant Formula Product and Services
Table 6. Abbott HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Abbott Recent Developments/Updates
Table 8. Mead Johnson?Reckitt? Basic Information, Manufacturing Base and Competitors
Table 9. Mead Johnson?Reckitt? Major Business
Table 10. Mead Johnson?Reckitt? HMO Infant Formula Product and Services
Table 11. Mead Johnson?Reckitt? HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Mead Johnson?Reckitt? Recent Developments/Updates
Table 13. Nestl??Wyeth Nutrition? Basic Information, Manufacturing Base and Competitors
Table 14. Nestl??Wyeth Nutrition? Major Business
Table 15. Nestl??Wyeth Nutrition? HMO Infant Formula Product and Services
Table 16. Nestl??Wyeth Nutrition? HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Nestl??Wyeth Nutrition? Recent Developments/Updates
Table 18. Danone (Aptamil) Basic Information, Manufacturing Base and Competitors
Table 19. Danone (Aptamil) Major Business
Table 20. Danone (Aptamil) HMO Infant Formula Product and Services
Table 21. Danone (Aptamil) HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Danone (Aptamil) Recent Developments/Updates
Table 23. FrieslandCampina (Friso) Basic Information, Manufacturing Base and Competitors
Table 24. FrieslandCampina (Friso) Major Business
Table 25. FrieslandCampina (Friso) HMO Infant Formula Product and Services
Table 26. FrieslandCampina (Friso) HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. FrieslandCampina (Friso) Recent Developments/Updates
Table 28. Biostime Basic Information, Manufacturing Base and Competitors
Table 29. Biostime Major Business
Table 30. Biostime HMO Infant Formula Product and Services
Table 31. Biostime HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Biostime Recent Developments/Updates
Table 33. Yili Group (Ausnutria Dairy) Basic Information, Manufacturing Base and Competitors
Table 34. Yili Group (Ausnutria Dairy) Major Business
Table 35. Yili Group (Ausnutria Dairy) HMO Infant Formula Product and Services
Table 36. Yili Group (Ausnutria Dairy) HMO Infant Formula Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Yili Group (Ausnutria Dairy) Recent Developments/Updates
Table 38. Global HMO Infant Formula Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 39. Global HMO Infant Formula Revenue by Manufacturer (2021-2026) & (USD Million)
Table 40. Global HMO Infant Formula Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 41. Market Position of Manufacturers in HMO Infant Formula, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 42. Head Office and HMO Infant Formula Production Site of Key Manufacturer
Table 43. HMO Infant Formula Market: Company Product Type Footprint
Table 44. HMO Infant Formula Market: Company Product Application Footprint
Table 45. HMO Infant Formula New Market Entrants and Barriers to Market Entry
Table 46. HMO Infant Formula Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global HMO Infant Formula Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 48. Global HMO Infant Formula Sales Quantity by Region (2021-2026) & (Tons)
Table 49. Global HMO Infant Formula Sales Quantity by Region (2027-2032) & (Tons)
Table 50. Global HMO Infant Formula Consumption Value by Region (2021-2026) & (USD Million)
Table 51. Global HMO Infant Formula Consumption Value by Region (2027-2032) & (USD Million)
Table 52. Global HMO Infant Formula Average Price by Region (2021-2026) & (US$/kg)
Table 53. Global HMO Infant Formula Average Price by Region (2027-2032) & (US$/kg)
Table 54. Global HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 55. Global HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 56. Global HMO Infant Formula Consumption Value by Type (2021-2026) & (USD Million)
Table 57. Global HMO Infant Formula Consumption Value by Type (2027-2032) & (USD Million)
Table 58. Global HMO Infant Formula Average Price by Type (2021-2026) & (US$/kg)
Table 59. Global HMO Infant Formula Average Price by Type (2027-2032) & (US$/kg)
Table 60. Global HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 61. Global HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 62. Global HMO Infant Formula Consumption Value by Sales Channel (2021-2026) & (USD Million)
Table 63. Global HMO Infant Formula Consumption Value by Sales Channel (2027-2032) & (USD Million)
Table 64. Global HMO Infant Formula Average Price by Sales Channel (2021-2026) & (US$/kg)
Table 65. Global HMO Infant Formula Average Price by Sales Channel (2027-2032) & (US$/kg)
Table 66. North America HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 67. North America HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 68. North America HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 69. North America HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 70. North America HMO Infant Formula Sales Quantity by Country (2021-2026) & (Tons)
Table 71. North America HMO Infant Formula Sales Quantity by Country (2027-2032) & (Tons)
Table 72. North America HMO Infant Formula Consumption Value by Country (2021-2026) & (USD Million)
Table 73. North America HMO Infant Formula Consumption Value by Country (2027-2032) & (USD Million)
Table 74. Europe HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 75. Europe HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 76. Europe HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 77. Europe HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 78. Europe HMO Infant Formula Sales Quantity by Country (2021-2026) & (Tons)
Table 79. Europe HMO Infant Formula Sales Quantity by Country (2027-2032) & (Tons)
Table 80. Europe HMO Infant Formula Consumption Value by Country (2021-2026) & (USD Million)
Table 81. Europe HMO Infant Formula Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Asia-Pacific HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 83. Asia-Pacific HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 84. Asia-Pacific HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 85. Asia-Pacific HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 86. Asia-Pacific HMO Infant Formula Sales Quantity by Region (2021-2026) & (Tons)
Table 87. Asia-Pacific HMO Infant Formula Sales Quantity by Region (2027-2032) & (Tons)
Table 88. Asia-Pacific HMO Infant Formula Consumption Value by Region (2021-2026) & (USD Million)
Table 89. Asia-Pacific HMO Infant Formula Consumption Value by Region (2027-2032) & (USD Million)
Table 90. South America HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 91. South America HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 92. South America HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 93. South America HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 94. South America HMO Infant Formula Sales Quantity by Country (2021-2026) & (Tons)
Table 95. South America HMO Infant Formula Sales Quantity by Country (2027-2032) & (Tons)
Table 96. South America HMO Infant Formula Consumption Value by Country (2021-2026) & (USD Million)
Table 97. South America HMO Infant Formula Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Middle East & Africa HMO Infant Formula Sales Quantity by Type (2021-2026) & (Tons)
Table 99. Middle East & Africa HMO Infant Formula Sales Quantity by Type (2027-2032) & (Tons)
Table 100. Middle East & Africa HMO Infant Formula Sales Quantity by Sales Channel (2021-2026) & (Tons)
Table 101. Middle East & Africa HMO Infant Formula Sales Quantity by Sales Channel (2027-2032) & (Tons)
Table 102. Middle East & Africa HMO Infant Formula Sales Quantity by Country (2021-2026) & (Tons)
Table 103. Middle East & Africa HMO Infant Formula Sales Quantity by Country (2027-2032) & (Tons)
Table 104. Middle East & Africa HMO Infant Formula Consumption Value by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa HMO Infant Formula Consumption Value by Country (2027-2032) & (USD Million)
Table 106. HMO Infant Formula Raw Material
Table 107. Key Manufacturers of HMO Infant Formula Raw Materials
Table 108. HMO Infant Formula Typical Distributors
Table 109. HMO Infant Formula Typical Customers
LIST OF FIGURES
Figure 1. HMO Infant Formula Picture
Figure 2. Global HMO Infant Formula Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global HMO Infant Formula Revenue Market Share by Type in 2025
Figure 4. 2'-Fucosyllactose (2'-FL) Examples
Figure 5. Others Examples
Figure 6. Global HMO Infant Formula Consumption Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 7. Global HMO Infant Formula Revenue Market Share by Sales Channel in 2025
Figure 8. Online Channel Examples
Figure 9. Specialty Store Examples
Figure 10. Supermarket Examples
Figure 11. Others Examples
Figure 12. Global HMO Infant Formula Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global HMO Infant Formula Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global HMO Infant Formula Sales Quantity (2021-2032) & (Tons)
Figure 15. Global HMO Infant Formula Price (2021-2032) & (US$/kg)
Figure 16. Global HMO Infant Formula Sales Quantity Market Share by Manufacturer in 2025
Figure 17. Global HMO Infant Formula Revenue Market Share by Manufacturer in 2025
Figure 18. Producer Shipments of HMO Infant Formula by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 19. Top 3 HMO Infant Formula Manufacturer (Revenue) Market Share in 2025
Figure 20. Top 6 HMO Infant Formula Manufacturer (Revenue) Market Share in 2025
Figure 21. Global HMO Infant Formula Sales Quantity Market Share by Region (2021-2032)
Figure 22. Global HMO Infant Formula Consumption Value Market Share by Region (2021-2032)
Figure 23. North America HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 26. South America HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 28. Global HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 29. Global HMO Infant Formula Consumption Value Market Share by Type (2021-2032)
Figure 30. Global HMO Infant Formula Average Price by Type (2021-2032) & (US$/kg)
Figure 31. Global HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 32. Global HMO Infant Formula Revenue Market Share by Sales Channel (2021-2032)
Figure 33. Global HMO Infant Formula Average Price by Sales Channel (2021-2032) & (US$/kg)
Figure 34. North America HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 35. North America HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 36. North America HMO Infant Formula Sales Quantity Market Share by Country (2021-2032)
Figure 37. North America HMO Infant Formula Consumption Value Market Share by Country (2021-2032)
Figure 38. United States HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 42. Europe HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 43. Europe HMO Infant Formula Sales Quantity Market Share by Country (2021-2032)
Figure 44. Europe HMO Infant Formula Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 46. France HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 51. Asia-Pacific HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 52. Asia-Pacific HMO Infant Formula Sales Quantity Market Share by Region (2021-2032)
Figure 53. Asia-Pacific HMO Infant Formula Consumption Value Market Share by Region (2021-2032)
Figure 54. China HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 57. India HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 60. South America HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 61. South America HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 62. South America HMO Infant Formula Sales Quantity Market Share by Country (2021-2032)
Figure 63. South America HMO Infant Formula Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa HMO Infant Formula Sales Quantity Market Share by Type (2021-2032)
Figure 67. Middle East & Africa HMO Infant Formula Sales Quantity Market Share by Sales Channel (2021-2032)
Figure 68. Middle East & Africa HMO Infant Formula Sales Quantity Market Share by Country (2021-2032)
Figure 69. Middle East & Africa HMO Infant Formula Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 71. Egypt HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 73. South Africa HMO Infant Formula Consumption Value (2021-2032) & (USD Million)
Figure 74. HMO Infant Formula Market Drivers
Figure 75. HMO Infant Formula Market Restraints
Figure 76. HMO Infant Formula Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of HMO Infant Formula in 2025
Figure 79. Manufacturing Process Analysis of HMO Infant Formula
Figure 80. HMO Infant Formula Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
